Use of CRISPR/Cas9 technique in cancer therapy was successful in bran cancer where the technique was used to introducing a Knock-out of Nf1, Pten, and Trp53 genes which are responsible for glioblastoma and Ptch1 gene responsible for [63]. Here, NF1 is linked to cancer.